Dian Diagnostics Group Co.,Ltd. (300244.SZ)
300244.SZ Stock Price Chart
Explore Dian Diagnostics Group Co.,Ltd. interactive price chart. Choose custom timeframes to analyze 300244.SZ price movements and trends.
300244.SZ Company Profile
Discover essential business fundamentals and corporate details for Dian Diagnostics Group Co.,Ltd. (300244.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
19 Jul 2011
Employees
8.77K
Website
https://www.dazd.cnCEO
Haibin Chen (EMBA)
Description
Dian Diagnostics Group Co.,Ltd. operates as a third-party independent medical diagnostic service company in China. It offers medical diagnosis solutions for various general hospitals and specialty hospitals, community health service centers, township health centers, physical examination centers, disease prevention and control centers, and other medical and health institutions. The company operates 40 chain laboratories worldwide. It also engages in the research, development, and production of in vitro diagnostic reagents and related equipment and consumables; provision of medical equipment, drugs, clinical samples, biological products, virus and microorganisms, finished blood, live animals, compounds, and diagnostic reagents, as well as other cold chain transportation, warehousing services, cold chain product sales, and technical services. The company was formerly known as Zhejiang DIAN Diagnostics Co., Ltd. and changed its name to Dian Diagnostics Group Co.,Ltd. in November 2017. Dian Diagnostics Group Co.,Ltd. was founded in 2001 and is based in Hangzhou, China.
300244.SZ Financial Timeline
Browse a chronological timeline of Dian Diagnostics Group Co.,Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 21 Aug 2025
EPS came in at ¥0.05 falling short of the estimated ¥0.08 by -37.50%, while revenue for the quarter reached ¥2.57B , missing expectations by -1.40%.
Dividend declared on 18 Jun 2025
A dividend of ¥0.25 per share was announced, adjusted to ¥0.25. The dividend was paid on 18 Jun 2025.
Earnings released on 28 Apr 2025
EPS came in at -¥0.03 falling short of the estimated ¥0.20 by -115.00%, while revenue for the quarter reached ¥2.35B , missing expectations by -19.33%.
Earnings released on 22 Apr 2025
EPS came in at -¥0.79 falling short of the estimated -¥0.33 by -139.39%, while revenue for the quarter reached ¥2.94B , beating expectations by +1.28%.
Earnings released on 23 Oct 2024
EPS came in at ¥0.10 falling short of the estimated ¥0.16 by -37.50%, while revenue for the quarter reached ¥3.04B , missing expectations by -10.95%.
Dividend declared on 20 Sept 2024
A dividend of ¥0.65 per share was announced, adjusted to ¥0.65. The dividend was paid on 20 Sept 2024.
Earnings released on 23 Aug 2024
EPS came in at ¥0.08 falling short of the estimated ¥0.28 by -71.43%, while revenue for the quarter reached ¥3.23B , missing expectations by -1.64%.
Dividend declared on 13 Jun 2024
A dividend of ¥0.06 per share was announced, adjusted to ¥0.06. The dividend was paid on 13 Jun 2024.
Earnings released on 20 Apr 2024
EPS came in at -¥0.35 falling short of the estimated ¥0.05 by -800.00%, while revenue for the quarter reached ¥2.96B , missing expectations by -12.94%.
Earnings released on 23 Feb 2024
EPS came in at -¥0.35 falling short of the estimated ¥0.05 by -800.00%, while revenue for the quarter reached ¥3.11B .
Earnings released on 27 Oct 2023
EPS came in at ¥0.12 falling short of the estimated ¥0.32 by -62.50%, while revenue for the quarter reached ¥3.45B , beating expectations by +5.19%.
Earnings released on 30 Aug 2023
EPS came in at ¥0.47 falling short of the estimated ¥0.53 by -11.32%, while revenue for the quarter reached ¥3.61B , beating expectations by 0.00%.
Dividend declared on 31 May 2023
A dividend of ¥0.20 per share was announced, adjusted to ¥0.20. The dividend was paid on 31 May 2023.
Earnings released on 26 Apr 2023
EPS came in at ¥0.26 falling short of the estimated ¥0.71 by -63.38%, while revenue for the quarter reached ¥4.65B , beating expectations by +11.07%.
Earnings released on 12 Apr 2023
EPS came in at -¥1.60 surpassing the estimated -¥1.61 by +0.62%, while revenue for the quarter reached ¥3.23B , missing expectations by -30.20%.
Earnings released on 26 Oct 2022
EPS came in at ¥0.88 surpassing the estimated ¥0.79 by +11.39%, while revenue for the quarter reached ¥4.88B , beating expectations by +5.22%.
Earnings released on 26 Aug 2022
EPS came in at ¥1.81 surpassing the estimated ¥1.01 by +79.21%, while revenue for the quarter reached ¥6.10B , beating expectations by +16.52%.
Dividend declared on 8 Jun 2022
A dividend of ¥0.14 per share was announced, adjusted to ¥0.14. The dividend was paid on 8 Jun 2022.
Earnings released on 26 Apr 2022
EPS came in at ¥1.22 surpassing the estimated ¥1.14 by +7.02%, while revenue for the quarter reached ¥4.65B , beating expectations by +40.62%.
Earnings released on 16 Apr 2022
EPS came in at -¥0.11 falling short of the estimated -¥0.04 by -182.49%, while revenue for the quarter reached ¥3.74B , beating expectations by +22.67%.
Earnings released on 22 Oct 2021
EPS came in at ¥0.80 surpassing the estimated ¥0.47 by +70.21%, while revenue for the quarter reached ¥3.55B .
Earnings released on 25 Aug 2021
EPS came in at ¥0.63 surpassing the estimated ¥0.58 by +8.62%, while revenue for the quarter reached ¥2.92B .
Dividend declared on 24 Jun 2021
A dividend of ¥0.13 per share was announced, adjusted to ¥0.13. The dividend was paid on 24 Jun 2021.
Earnings released on 27 Apr 2021
EPS came in at ¥0.54 , while revenue for the quarter reached ¥3.18B .
Earnings released on 10 Apr 2021
EPS came in at ¥0.54 , while revenue for the quarter reached ¥2.87B .
Earnings released on 28 Oct 2020
EPS came in at ¥0.64 , while revenue for the quarter reached ¥3.00B .
300244.SZ Stock Performance
Access detailed 300244.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.